Zymeworks (ZYME) Tops Q3 EPS by 23c

Zymeworks (NYSE: ZYME) reported Q3 EPS of ($0.66), $0.23 better than the analyst estimate of ($0.89). Revenue for the quarter came in at $2.6 million versus the consensus estimate of $5.55 million.

For earnings history and earnings-related data on Zymeworks (ZYME) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• Ardent Health revises 2025 non-GAAP figures after SEC staff talks
• SoundHound AI completes LivePerson acquisition, names new CFO